Unlock Faster, More Relevant Demyelination Research with Human ioOPC-like Cells

Human-relevant Oligodendrocyte Precursor Models, Ready When Your Experiments Are

Are you planning studies on demyelinating or neurodegenerative disease and need a more consistent, physiologically relevant in vitro model? Introducing ioOPC-like cells from bit.bio, cryopreserved human iPSC-derived oligodendrocyte precursor-like cells designed to help you move from thaw to data in days, not weeks. Whether you're investigating remyelination, OPC differentiation, oligodendrocyte loss, or disease mechanisms such as multiple sclerosis, ioOPC-like cells give you reliable access to the cell types that matter most.

Why Researchers Choose ioOPC-like Cells

Powered by opti-ox™ deterministic cell programming technology, ioOPC-like cells arrive cryopreserved and ready to culture, reducing lengthy differentiation workflows and batch variability.

These cells closely resemble the human OPC phenotype and retain the ability to mature into oligodendrocyte-like cells, helping you generate more relevant data.

Ideal for studies focused on:

• Demyelinating diseases, including multiple sclerosis
• Neurodegeneration
• Remyelination biology
• OPC proliferation and differentiation
• Myelin formation and repair pathways

Proven Biological Relevance

ioOPC-like cells demonstrate expression of key oligodendroglial markers, including:

• O4 during early maintenance phases
• MBP upon maturation
• PDGFRA
• CSPG4

This gives you confidence that your model reflects meaningful oligodendrocyte lineage biology.

Figure 1: Immunocytochemistry staining shows expression of key markers throughout culture. At Days 1, 7 and 14, cells are positive for the oligodendrocyte-specific marker O4 (green) with DAPI counterstain (blue). By Day 21, following the second passage and maturation media switch, cells display increased complexity and are positive for O4 (green), MBP (red), and DAPI (blue).

Figure 2: Following deterministic programming, cells undergo rapid morphological changes across culture phases. From Day 1 to Day 7, cells display OPC-like morphology. After the first passage (Days 8–14), this phenotype is maintained. Following the second passage, cells mature rapidly and by Day 21 exhibit oligodendrocyte-like morphology.

A common challenge in OPC research is balancing expansion with downstream maturation.

ioOPC-like cells are designed to support both:

• Expandable and passagable for up to two weeks
• OPC-like morphology during maintenance
• Rapid maturation toward oligodendrocyte-like cells by Day 21

This flexibility helps you align culture timing with your assay needs.

Need to assess proliferation?

bit.bio has developed a dedicated Click-iT™ EdU proliferation assay protocol for ioOPC-like cells, helping you generate accurate and reproducible proliferation data with confidence.

Figure 3: Immunostaining after Click-iT™ EdU treatment at Day 9 (two days post first passage) shows cells positive for O4 (red), EdU (green), and DAPI (blue), confirming active proliferation within the culture.

Figure 4: RT-qPCR analysis confirms robust expression of relevant oligodendroglial markers including PDGFRA and CSPG4 across Days 1, 7, 14 and 21 post-revival (normalised to housekeeping gene HMBS).

Upon revival, ioOPC-like cells immediately exhibit characteristic oligodendrocyte precursor morphology and express key progenitor genes.

Special 3-Vial Pack for Academic Researchers

Get cost-effective access for larger projects, pilot studies, or replicate-heavy workflows:

ioOPC-like cells – 3 Vial Pack: 3 × >1 x 10⁶ viable cells

Ideal for university labs and publicly funded research teams seeking better value without compromising model quality.

Instead of spending valuable time generating cells, troubleshooting differentiation, or managing inconsistent batches, you can focus on what matters most:

• Testing hypotheses faster
• Producing stronger translational data
• Accelerating publication timelines
• Advancing therapeutic discovery

Discover how ioOPC-like cells can support your next project.

Request pricing, technical information, or your academic 3-pack today.

Need help selecting the right human-relevant oligodendrocyte precursor models

Our team of experts can guide you in choosing the most relevant cells models for your research goals.